The capsule’s structure — hollow except for polymer chains tethered to the interior of the shell — provides spatially segregated compartments that make it a good candidate for multi-drug encapsulation and release strategies.
The microcapsule, which measures less than one micron, could be used to simultaneously deliver distinct drugs by filling the core of the capsule with hydrophilic drugs and trapping hydrophobic drugs within nanoparticles assembled from the polymer chains.
‘We have demonstrated that we can make a fairly complex multi-component delivery vehicle using a relatively straightforward and scalable synthesis,’ said L Andrew Lyon, a professor in the School of Chemistry and Biochemistry at Georgia Tech. ‘Additional research will need to be conducted to determine how they would best be loaded, delivered and triggered to release the drugs.’
The researchers began the two-step synthesis procedure by forming core particles from a temperature-sensitive polymer called poly (N-isopropylacrylamide).
To create a dissolvable core, they formed polymer chains from the particles without a cross-linking agent, which resulted in an aggregated collection of polymer chains with temperature-dependent stability.
‘The polymer comprising the core particles is known for undergoing chain transfer reactions that add cross-linking points without the presence of a cross-linking agent, so we initiated the polymerisation using a redox method with ammonium persulphate and N,N,N’,N’-tetramethylethylenediamine.
‘This ensured those side-chain transfer reactions did not occur, which allowed us to create a truly dissolvable core,’ said Lyon.
For the second step in the procedure, Lyon and Xiaobo Hu, a former visiting scholar at Georgia Tech, added a cross-linking agent to a polymer called poly (N-isopropylmethacrylamide) to create a shell around the aggregated polymer chains.
The researchers conducted this step under conditions that would allow any core-associated polymer chains that interacted with the shell during synthesis to undergo chain transfer and become grafted to the interior of the shell.
Cooling the microcapsule exploited the temperature-sensitivities of the polymers. The shell swelled with water and expanded to its stable size, while the free-floating polymer chains in the centre of the capsule diffused out of the core, leaving behind an empty space. Any chains that stuck to the shell during its synthesis remained.
Because the chains control the interaction between the particles they store and their surroundings, the tethered chains can act as hydrophobic drug carriers.
Compared to delivering a single drug, co-delivery of multiple drugs is said to have several potential advantages, including synergistic effects, suppressed drug resistance and the ability to tune the relative dosage of various drugs.
The future optimisation of these microcapsules may allow simultaneous delivery of distinct classes of drugs for the treatment of diseases such as cancer, which is often treated using combination chemotherapy.
Oxa launches autonomous Ford E-Transit for van and minibus modes
I'd like to know where these are operating in the UK. The report is notably light on this. I wonder why?